Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, 2026, the Compensation Committee of Recursion's Board of ...
Abstract: An efficient recursive aggregated centered transition matrix (T-matrix) algorithm (RACTMA) to analyze electromagnetic scattering from many randomly distributed obstacles is derived. The ...
Abstract: Building collapses, irrespective of structure type or location, result in global tragedies. Rapid rescue efforts are essential, especially within the critical three-day window for trapped ...
The spotlight is now firmly on clinical validation for Exscientia following its merger with Recursion Pharmaceuticals. The company’s core artificial intelligenc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results